HCPCS Level IIdrugActive
J0491
Inj anifrolumab-fnia 1mg
BETOS: O1E
Effective: 2022-04-01
Referenced in 1 policies
Description
Injection, anifrolumab-fnia, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Saphnelo
Manufacturer
AstraZeneca Pharmaceuticals LP
HCPCS Dosage
1 MG
Billing Units
300.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.